Angewandte Chemie · 2018 · 14 citations · 29 references
PharmacyMedicinal ChemistryMolecular BiologyDrug DesignDrug DiscoveryMolecular RecognitionBiomolecular InteractionsFragment-based Drug DesignLigand BindingPharmacophore ScreeningSmall-molecule ScreeningDna OrigamiDrug ScreeningFragment-based DiscoveryFragment-based Pharmacophore ScreeningLead Compound DiscoveryLigand-binding AssaysProtein-ligand Interaction PharmacophoresTarget-ligand Interactions
Abstract The rational combination of techniques from the fields of nanotechnology, single molecule detection, and lead discovery could provide elegant solutions to enhance the throughput of drug screening. We have synthesized nanoarrays of small pharmacophores on DNA origami substrates that are displayed either as individual ligands or as fragment pairs and thereby reduced the feature size by several orders of magnitude, as compared with standard microarray techniques. Atomic force microscopy‐based single‐molecule detection allowed us to distinguish potent protein–ligand interactions from weak binders. Several independent binding events, that is, strong, weak, symmetric bidentate, and asymmetric bidentate binding are directly visualized and evaluated. We apply this method to the discovery of bidentate trypsin binders based on benzamidine paired with aromatic fragments. Pairing of benzamidine with the dye TAMRA results in tenfold enhancement of the trypsin binding yield.
29
Folding DNA to create nanoscale shapes and patterns
Paul W. K. Rothemund · Nature · 2006 · 7.4K citations
Designer nanoscale DNA assemblies programmed from the top down
Rémi Veneziano, Sakul Ratanalert, Kaiming Zhang et al. · Science · 2016 · 641 citations · Full text
Biotechnological mass production of DNA origami
Florian Praetorius, Benjamin Kick, Karl L. Behler et al. · Nature · 2017 · 524 citations · Full text
DNA-Templated Organic Synthesis and Selection of a Library of Macrocycles
Zev J. Gartner, Brian N. Tse, Rozalina Grubina et al. · Science · 2004 · 516 citations · Full text